This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Xarelto
  • /
  • A Study Exploring Two Strategies of Rivaroxaban (J...
Clinical trial

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Read time: 3 mins
Last updated:10th May 2013
Identifier: NCT01830543
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest